ATRA Stock Analysis: Buy, Sell, or Hold?
ATRA - Atara Biotherapeutics, Inc
$11.65
0.28 (2.46%)
▲
5d:
+13.99%
30d:
+17.68%
90d:
+125.34%
HOLD
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 10, 2026
Get Alerted When ATRA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ATRA shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: ATRA shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$30.07
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$18.67
37.6% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 16.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ATRA is currently trading at $11.65, which is considered extended relative to its 30-day fair value range of $9.76 to $10.99. From a valuation perspective, the stock is trading at a discount (Forward PE: 9.2) compared to its historical average (16.9). Remarkably, the market is currently pricing in an annual earnings decline of 18.5% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, ATRA is in a strong uptrend. Immediate support is located at $9.57, while resistance sits at $12.00.
Market Sentiment: ATRA has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $13.67 (+17.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ATRA is in a strong uptrend. Immediate support is located at $9.57, while resistance sits at $12.00.
Market Sentiment: ATRA has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $13.67 (+17.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$9.76 -
$10.99
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
54.8%
All Signals
- BEARISH: Price extended above range (+6.0% above its trading range)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($13.67)
Trading Range Analysis
30-Day Trading Range
$9.76 -
$10.99
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$9.57
Resistance Level
$12.00
Current Trend
Strong Uptrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
9.17
Wall Street Target
$13.67
(+17.3%)
Revenue Growth (YoY)
-99.5%
Profit Margin
-40.9%
Valuation Discount vs History
-18.5% cheaper
PE vs Historical
9.2 vs 16.9
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-18.5%
(market-implied from PE analysis)
1-Year Target
$10.48
(-10%)
2-Year Target
$9.44
(-19%)
3-Year Target
$8.49
(-27%)
3-Yr Target (if PE normalizes)
(PE: 9→17)
$15.65
(+34%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 9.2 to 16.9
Stabilization Target:
$21.46
(+84.2%)
PE Expansion Potential:
+84.2%
Share & Embed Analysis
Last updated: July 03, 2026 7:13 PM ET
Data refreshes hourly during market hours. Next update: 8:13 PM
Data refreshes hourly during market hours. Next update: 8:13 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ATRA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Innovation Ltd Panacea
SELL
80554 shares
2026-01-12
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1041 | 62 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$106 | 64 BUY |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$57 | 51 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$276 | 55 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
